Exagen refinances $27.2M term loan with Innovatus; maturity extended to Nov 2026

EXAGEN INC.

$27.2M term loan at 8.0% interest (2% paid in-kind) from Innovatus.
Interest-only period extended through December 2024; maturity extended to November 19, 2026.
Financial covenant revised to revenue-based test starting Q4 2022, with cure options via equity or sub debt.
Effective November 1, 2021; press release issued October 25, 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.